Drugmaker Moderna said its experimental COVID-19 vaccine has shown promising results in a small early-stage human trial. Details here:
- Early data from Moderna Inc’s COVID-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small group of healthy volunteers, the company said on Monday.
An analysis of the response in the eight individuals showed that those who received a 100 microgram dose and a 25 microgram dose had levels of protective antibodies to fend of the virus that exceeded those found in the blood of people who recovered from COVID-19, the illness caused by the coronavirus.
Scientists are trying to understand what level of antibodies will ultimately prove protective against the novel coronavirus, and how long that protection will last. The vaccine has gotten the green light to start the second stage of human testing. Last week, U.S. regulators gave the vaccine “fast-track” status to speed up the regulatory review.
The U.S. government in April placed a big bet on Moderna, backing its vaccine with $483 million from the Biomedical Advanced Research and Development Authority , a part of the U.S. Department of Health and Human Services . “We are investing to scale up manufacturing so we can maximize the number of doses we can produce to help protect as many people as we can from SARS-CoV-2,” Moderna Chief Executive Officer Stéphane Bancel said, using the official name for the new virus.FILE PHOTO: Small bottles labeled with a"Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
With 19 Confirmed COVID-19 Cases And No Deaths, Laos To Loosen LockdownLaos has zero reported COVID-19 deaths and confirmed cases have held steady at 19 for over a month. Now, officials are further lifting lockdown restrictions.
Read more »
Moderna's COVID-19 vaccine shows early promise; shares soarEarly data from Moderna Inc's COVID-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small group of healthy volunteers, the company said on Monday.
Read more »
Martin Shkreli Denied Early Prison Release Over COVID-19The hated Pharma Bro will continue to serve his sentence in prison.
Read more »
Llama Antibodies Neutralize Virus That Causes COVID-19, New Research ShowsA new study shows that antibodies from llamas can neutralize the virus that causes COVID-19. It started in 2016 with a llama named Winter — who's now 'grazing peacefully on a farm in Belgium,' one researcher tells vprnet.
Read more »
Experts: COVID-19 shows U.S., U.K. are vulnerable to biological terrorismThe coronavirus pandemic has exposed a structural vulnerability to biological attacks in the U.S. and Europe that requires urgent government action, experts say.
Read more »
Moderna's COVID-19 vaccine shows positive results, moves to larger studiesNEW: COVID-19 vaccine candidate shows promise in early results of phase 1 trial, with patients who received two doses of the vaccine developing neutralizing antibodies. The drug is now being tested in larger studies.
Read more »